<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Bayliss EA</submitter><funding>NIA NIH HHS</funding><funding>National Institute on Aging</funding><pagination>2487-2497</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9489620</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>70(9)</volume><pubmed_abstract>Interpreting results from deprescribing interventions to generate actionable evidence is challenging owing to inconsistent and heterogeneous outcome definitions between studies. We sought to characterize deprescribing intervention outcomes and recommend approaches to measure outcomes for future studies. A scoping literature review focused on deprescribing interventions for polypharmacy and informed a series of expert panel discussions and recommendations. Twelve experts in deprescribing research, policy, and clinical practice interventions participating in the Measures Workgroup of the US Deprescribing Research Network sought to characterize deprescribing outcomes and recommend approaches to measure outcomes for future studies. The scoping review identified 125 papers reflecting 107 depres</pubmed_abstract><journal>Journal of the American Geriatrics Society</journal><pubmed_title>Recommendations for outcome measurement for deprescribing intervention studies.</pubmed_title><pmcid>PMC9489620</pmcid><funding_grant_id>R24 AG064025</funding_grant_id><funding_grant_id>P30 AG024824</funding_grant_id><funding_grant_id>R24AG064025</funding_grant_id><pubmed_authors>Rich MW</pubmed_authors><pubmed_authors>Gleason K</pubmed_authors><pubmed_authors>Ensrud KE</pubmed_authors><pubmed_authors>Vasilevskis EE</pubmed_authors><pubmed_authors>Bayliss EA</pubmed_authors><pubmed_authors>Gray SL</pubmed_authors><pubmed_authors>Boyd CM</pubmed_authors><pubmed_authors>Linsky AM</pubmed_authors><pubmed_authors>Campbell NL</pubmed_authors><pubmed_authors>Min L</pubmed_authors><pubmed_authors>Dublin S</pubmed_authors><pubmed_authors>Turner J</pubmed_authors><pubmed_authors>Albers K</pubmed_authors><pubmed_authors>Steinman MA</pubmed_authors><pubmed_authors>Pieper LE</pubmed_authors><pubmed_authors>Mangin D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Recommendations for outcome measurement for deprescribing intervention studies.</name><description>Interpreting results from deprescribing interventions to generate actionable evidence is challenging owing to inconsistent and heterogeneous outcome definitions between studies. We sought to characterize deprescribing intervention outcomes and recommend approaches to measure outcomes for future studies. A scoping literature review focused on deprescribing interventions for polypharmacy and informed a series of expert panel discussions and recommendations. Twelve experts in deprescribing research, policy, and clinical practice interventions participating in the Measures Workgroup of the US Deprescribing Research Network sought to characterize deprescribing outcomes and recommend approaches to measure outcomes for future studies. The scoping review identified 125 papers reflecting 107 depres</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2025-04-04T07:44:10.395Z</modification><creation>2025-04-04T07:44:10.395Z</creation></dates><accession>S-EPMC9489620</accession><cross_references><pubmed>35648465</pubmed><doi>10.1111/jgs.17894</doi></cross_references></HashMap>